A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Codeine-N-oxide
Ribociclib
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Ribociclib.
Codeine-N-oxide
Lumefantrine
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Lumefantrine.
Codeine-N-oxide
Artemether
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Artemether.
Codeine-N-oxide
Asenapine
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Asenapine.
Codeine-N-oxide
Iloperidone
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Iloperidone.
Codeine-N-oxide
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Tetrabenazine.
Codeine-N-oxide
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Zuclopenthixol.
Codeine-N-oxide
Magnesium lactate
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium lactate.
Codeine-N-oxide
Magnesium levulinate
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium levulinate.
Codeine-N-oxide
Magnesium orotate
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium orotate.
Codeine-N-oxide
Magnesium gluconate
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium gluconate.
Codeine-N-oxide
Magnesium peroxide
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium peroxide.
Codeine-N-oxide
Magnesium aspartate
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium aspartate.
Codeine-N-oxide
Hydrotalcite
The risk or severity of hypotension can be increased when Dexverapamil is combined with Hydrotalcite.
Codeine-N-oxide
Magnesium silicate
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium silicate.
Codeine-N-oxide
Magnesium citrate
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium citrate.
Codeine-N-oxide
Magnesium chloride
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium chloride.
Codeine-N-oxide
Magnesium trisilicate
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium trisilicate.
Codeine-N-oxide
Magnesium hydroxide
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium hydroxide.
Codeine-N-oxide
Magaldrate
The risk or severity of hypotension can be increased when Dexverapamil is combined with Magaldrate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3